Digital therapeutics market seen topping $37.8B by 2030

The digital therapeutics market is projected to surge from $10.93 billion in 2025 to $14.02 billion in 2026, with North America in the lead and Asia-Pacific expected to grow fastest. The market could reach $37.82 billion by 2030 as chronic disease rates, reimbursement support and AI-powered care tools expand adoption.

Why it matters: - Digital therapeutics are moving from a niche digital health category into a larger part of medical care. - Faster adoption could expand access to evidence-based treatment for chronic conditions and support lower-friction care delivery. - The market’s projected growth signals stronger commercial demand for software-based therapies across healthcare systems.

What happened: - The Business Research Company released its Digital Therapeutics Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the market will rise from $10.93 billion in 2025 to $14.02 billion in 2026. - The forecast implies 28.3% growth in 2026. - The market is projected to reach $37.82 billion by 2030. - The report links the forecast period to a 28.1% CAGR. - Download a free sample of the digital therapeutics market report. - View the full digital therapeutics market report.

The details: - Digital therapeutics use high-quality software to deliver evidence-based interventions for preventing, managing or treating medical conditions. - The report points to increased smartphone use in healthcare, broader acceptance of digital health tools, telemedicine expansion, early regulatory clearances and rising chronic disease burden as drivers of recent growth. - Future growth is expected to benefit from improved reimbursement policies, demand for personalized digital care, AI-powered treatment platforms, deeper provider-tech partnerships and preventive care delivered digitally. - Key trends include wider use of software-based therapeutic solutions, more wearable health devices, growth in remote patient monitoring, expansion of evidence-based digital care programs and more tailored treatment strategies. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Chronic disease growth is a key demand signal because digital therapeutics can provide ongoing, evidence-based support between clinical visits. - The combination of reimbursement progress and AI-enabled platforms suggests the market is shifting from experimentation toward scaled deployment. - North America’s lead reflects mature healthcare infrastructure, while Asia-Pacific’s faster growth points to rising digital health adoption in less saturated markets.

What's next: - The report expects continued market expansion through 2030 and beyond as digital care models gain traction. - Broader reimbursement, stronger partnerships and more preventive-care use cases could shape which companies win share. - Adoption of remote monitoring and wearable-linked therapy programs is likely to remain a major growth area.

The bottom line: - Digital therapeutics are on a steep growth path, with chronic disease pressure, digital adoption and policy support pushing the market toward $37.82 billion by 2030.